Nerve block for pain relief after robotic thymus gland surgery
Tests a chest nerve block for pain after robotic thymectomy in adults.
Key facts
- Who runs it
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Serratus Posterior Superior Intercostal Plane Block in Robotic-Assisted Thymectomy
- Status
- Recruiting
- People taking part
- 28 people, planned
- Started
- 1 Mar 2025
- Planned end
- 15 Sept 2026
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Ultrasound-guided Serratus Posterior Superior Intercostal Plane Block performed with 0.25% bupivacaine
- Ultrasound-guided Serratus Posterior Superior Intercostal Plane Block performed with a placebo solution (0.9% NaCl)
- Record updated
- 25 March 2025
Who can take part
The trial is looking for adults having robotic surgery to remove the thymus gland. It tests whether a numbing injection in the upper back eases pain after surgery.
- Age
- 18 Years and older
- Sex
- All sexes
- Disease stage
- Thymoma, thymic hyperplasia (an enlarged thymus), or other thymus problems such as cysts or teratomas.
- Earlier treatment
- People who had earlier chest surgery, or a chest injury with broken ribs, on the side of the surgery cannot join.
- Main reasons for not taking part
- Myasthenia gravis, severe obesity (BMI > 35), or a history of OSAS (sleep apnea), with or without CPAP
- ASA class > 3 (high risk for anesthesia)
- Allergy to pain or anesthetic drugs, or taking blood thinners (anticoagulants)
- History of chronic pain, or infection where the injection is given
- Chest deformities or nerve-muscle diseases that affect breathing
Show the full registry criteria (11)Hide the full registry criteria
Who can take part
- Patients affected by thymoma, thymic hyperplasia, or thymic pathologies (cysts, teratomas) who have given informed consent to the study
Who cannot take part
- Patients on anticoagulant therapy
- Patients who have had previous thoracic surgery and/or thoracic trauma with rib fractures on the side of the surgery
- Patients with myasthenia gravis, severe obesity (BMI > 35), history of OSAS with or without CPAP
- Patients with allergies to analgesic and/or anesthetic drugs
- Patients with a history of chronic pain
- Patients with an infection at the site where SPSIPB will be performed
- Patients with chest deformities and/or neuromuscular diseases that interfere with normal ventilatory function; Additionally, patients whose surgery is intraoperatively converted to sternotomy thymectomy will be excluded post-hoc from the study
- Patients who refuse to participate in the study by not signing the informed consent
- Patients belonging to ASA classes > 3, according to the system developed by the American Society of Anesthesiologists
- Patients unable to understand the functioning of the NPR Scale or the PCA device that will be used for postoperative analgesia
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
This trial is currently available in Italy.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to assess the effectiveness of the Serratus Posterior Superior Intercostal Plane Block (SPSIP Block) for postoperative pain control, reducing opioid analgesic consumption, minimizing postoperative respiratory complications, and enhancing patient satisfaction (measured using the QoR-15 index) in patients undergoing robotic thymectomy, compared to patients who do not receive the block.
The 2 groups in the trial
- SPSIP groupTreatment being tested
Patients in this group will be treated with the Serratus Posterior Superior Intercostal Plane Block, administered under ultrasound guidance 15 minutes before surgery in the operating room. The block will be performed by administering 30 ml of 0.25% bupivacaine.
Treatment: Ultrasound-guided Serratus Posterior Superior Intercostal Plane Block performed with 0.25% bupivacaine
- Placebo groupPlacebo, for comparison
Patients in this group will be treated with the Serratus Posterior Superior Intercostal Plane Block, administered under ultrasound guidance 15 minutes before surgery in the operating room. The block will be performed using 30 ml of a placebo solution without an active ingredient (0.9% NaCl)
Treatment: Ultrasound-guided Serratus Posterior Superior Intercostal Plane Block performed with a placebo solution (0.9% NaCl)
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 1 eligibility question with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Use of Serratus Posterior Superior Intercostal Plane Block in Robotic-Assisted Thoracoscopic Surgery for Thymectomy: A Randomized Controlled Trial
- Plain-language title
- Nerve block for pain relief after robotic thymus gland surgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT06545409, who can take part
- Record updated
- 25 March 2025